DURING the course of previous studies of
Raynaud's disease in women and girls,' and of patients with systemic scleroderma,2 we encountered the records of 71 patients with Raynaud's disease and secondary selerodermatous changes confined to the digits (sclerodactylia). These patients all had Raynaud's disease as defined by the criteria of Allen and Brown,3 namely: (1) episodes of Raynaud's phenomenon precipitated by cold or emotion, (2) bilaterality of the phenomenon, (3) absence of gangrene or the presence of only minimal degrees of cutaneous gangrene of the digits, (4) absence of any systemic disease that might account for the occurrence of Raynaud's phenomenon, and (5) duration of symptoms of 2 years or longer. In addition to the Raynaud's disease, all 71 patients had sclerodermatous changes in one or more digits when first examined at the Mayo Clinic, but none had any evidence of cutaneous sclerosis in other sites or of systemic seleroderma.
Because of the confusion that has resulted from the various classifications of scleroderma, and in light of O'Leary and Waisman's contention4 that patients with Raynaud's disease and sclerodactylia should be considered to have systemic scleroderma of a type that they called " acrosclerosis, " it was thought worth while to conduct a follow-up study of these patients. Follow-up information was obtained from all of the patients at re-examination at the clinic or by correspondence or both.
Preliminary Amputations of digits had been performed for 3 patients (4 per cent), involving amputation of single digits in 2 instances and of 2 digits in 1 case. These were performed primarily because of the presence of trophic changes; extensive gangrene was not observed.
Results of Follow-up Study Except for 1 patient who died within a year, the time of follow-up after the original diagnosis at the clinic ranged from 2 to 31 years, the average being about 10 years for the entire group. Of the 40 patients treated medically, 10 reported that the condition had improved, 10 thought it worse, and 17 believed it was unchanged. Three patients were dead. Among the 31 patients treated surgically, 10 believed the condition to be better, 6 worse, and 12 about the same ( the Raynaud's phenomenon had involved the feet also and that the seleroderma had extended to the arms, chest, and face. A report in 1951 stated that the seleroderma had progressed and that the patient had a "heart ailment." According to a letter received in January 1960, the sclerosis has remained about the same, but the patient now has dysphagia. Case 2 A 21-year-old woman was seen at the clinic in 1942 with Raynaud's phenomenon, involving both hands, which had been present for 5 years. No underlying cause could be determined, and no trophic changes were found, but sclerodactylia was noted. All peripheral arteries were pulsating normally. A cervicothoracic sympathectomy was performed. A follow-up letter in 1951 revealed that the sclerosis had increased and involved both arms as well as the hands; trophic changes of the digits had developed. In addition, progressive dysphagia had been present for 6 years. Case 3 A 23-year-old woman was first seen at the clinic in 1926 with Raynaud's phenomenon, involving the hands, of 6 years' duration. Trophic changes and selerodactylia were present. The peripheral arteries were pulsating normally, and no primary systemic disease or organic arterial disorder was found. A right cervical sympathetic ramisection was performed at that time. The patient returned in 1932, and because of a poor result from the first operation a bilateral cervicothoracic sympathetic ganglionectomy was performed. A letter from her physician in 1943 described changes involving the arms, face, and hands that were consistent with a diagnosis of seleroderma. The patient was seen again at the clinic in 1957, and a diagnosis of scleroderma was made. At this time the Raynaud's phenomenon was unchanged, but selerodermatous changes of Circulation, Volume XXIII, January 1961 the skin on the hands, arms, face, and trunk were noted. Caleinosis cutis was present in the hands, and there were trophic changes of the digits. A letter received in January 1960 indicated that the patient's condition has remained about the same.
In the first 2 cases the subsequent diagnosis of systemic scleroderma is only presumptive; however, the subjective complaints by the patients make this diagnosis likely. The third patient was re-examined at the clinic and the diagnosis of systemic scleroderma was confirmed. Discussion
The relationship between systemic scleroderma and selerodermatous changes confined to the digits (sclerodactylia) occurring secondary to long-standing Raynaud 's disease has not been clear. However, in this study only 4 per cent of the patients who originally had Raynaud 's disease and sclerodactylia were found to have developed systemic scleroderma, and there seems to be no justification for the belief that the two are the same disease. The incidence of selerodactylia has been reported as being 10 to 12 per cent among patients with Raynaud's disease. 4 It should be emphasized that selerodactylia is often a late development and, as the current study bears out, is frequently associated with trophic changes. The total number of patients with trophic changes, including those in whom these changes developed during the period of follow-up, was 34 (48 per cent).
As mentioned, only patients who had Raynaud's phenomenon for at least 2 years prior to the diagnosis of Raynaud 's disease were included in this study. Sclerodermatous changes in the digits among patients who have had Raynaud's phenomenon for less than 2 years often represent an early sign of systemic scleroderma. However, after the diagnosis of Raynaud's disease has been established, the development of sclerodactylia will be followed by systemic involvement only rarely (4 per cent in this study). The use of strict criteria for the diagnosis of Raynaud's disease will help to prevent mistakes in distinguishing between systemic scleroderma with secondary Raynaud's phenomenon and Raynaud's disease with selerodactylia. The correct diagnosis is important because of the vastly different prognosis of these two conditions.
A recent study2 of 271 patients with systemic scleroderma revealed that about half of those who were traced died during a followup period which averaged 8.5 years. However, in the current series of 71 patients with Raynaud 's disease and sclerodactylia, only 8.4 per cent died during the follow-up period, and none of these had systemic scleroderma.
Summary and Conclusions
The records of 71 patients with Raynaud's disease and selerodactylia seen at the Mayo Clinic were studied. Follow-up information was obtained for all, with periods varying from 1 to 31 years. Systemic scleroderma seemed to have developed in only 3 patients. Six patients had died but none from systemic scleroderma. This study does not support the belief that systemic seleroderma and sclerodactylia secondary to Raynaud's disease are the same disease.
